Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: Dan Spillane who wrote (1858)	3/30/1999 7:20:00 PM
From: Anthony Wong	Respond to of 2539

03/30 16:45 Searle's Celebrex weekly prescriptions top Viagra CHICAGO, March 30 (Reuters) - Weekly prescriptions for the new arthritis drug, Celebrex, from Monsanto's <MTC.N> G.D. Searle unit rose to more than 320,000, topping the best week ever for Pfizer's anti-impotence drug Viagra, according to new data. NDC Health Information Services said for the week ended Sunday, the 10th week the product was on the market, Celebrex prescriptions totalled 322,000, which compared with 310,000 prescriptions for Viagra during its best-selling week. Celebrex's new prescription market share reached another high on Thursday and Friday of last week at nearly 24 percent, the organization said. moneynet.com@NEWS-P1&Index=2&HeadlineURL=../News/NewsHeadlines.asp&DISABLE_FORM=&NAVSVC=News\Company

To: Dan Spillane who wrote (1858)	3/30/1999 7:35:00 PM
From: Anthony Wong	Respond to of 2539

03/30 18:46 Pioneer sees pest-resistant corn seeds by 2002 DES MOINES, Iowa, March 30 (Reuters) - Pioneer Hi-Bred International Inc. <PHB.N> said Tuesday it could have corn seeds that fight corn rootworm, a pest that does an estimated $1 billion in damage to the North American corn crop each year, on the market by 2002. Aggressive testing on several different sources of resistance will continue at Pioneer this year to determine which new genes will achieve the most effective corn-rootworm resistance, the company said. "If the products move through U.S. EPA (Environmental Protection Agency) and other regulatory reviews as planned, we believe we could bring corn rootworm-resistant hybrids to the marketplace by 2002," Tom Czapla, Pioneer research manager, said in a statement. Pioneer rival Monsanto Co. <MTC.N>. said last August it had genetically engineered corn to resist rootworm. At the time, Monsanto noted that commercial introduction of a rootworm-resistant corn seed would probably come in 2001 or 2002. Pioneer, the leading U.S. seed breeder, earlier Tuesday reported a second-quarter profit of $3.0 million, or 1 cent per diluted share, reversing a year-ago loss of $1.0 million, or 1 cent a share. Shares of the company, which is being acquired by chemical giant DuPont Co. <DD.N>, closed 37-3/4 in composite New York Stock Exchange trading on Tuesday, unchanged from Monday's settlement.